Proxima
Proxima (Proxima Bio) is a preclinical biotechnology company making protein interactions programmable through an integrated discovery platform that combines artificial intelligence, machine learning, and structural proteomics. Building on a proprietary atlas of protein cross-linking data, Proxima trains models that design proximity modulators - Inducers, Modulators, and Blockers - small-molecule therapeutics that induce or block protein-protein complexes to address cancer, autoimmune disorders, and other hard-to-treat diseases. The company is backed by DCVC and collaborates with major pharmaceutical firms. It is listed in the API Evangelist network as a company profile; as of this pass Proxima publishes no public developer API, SDK, or developer portal.
Proxima is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Machine Learning.
Proxima’s developer surface includes engineering blog and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 3
The organization behind the API